Kedar Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.50 Cr
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.00 Cr
- Revenue Growth %
- Profit Growth -3042.79%
- Ebitda -5271.11%
- Net Worth 45040.00%
- Total Assets 289.51%
About Kedar Drugs And Pharmaceuticals
Kedar Drugs And Pharmaceuticals Private Limited (KDAPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 24 March 2022 (Two years and 11 months 3 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹11.00 Cr.
Vimal Mehta, Parveen Kumar, and Puneet Kathuria serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290DL2022PTC395470
- Company No.
395470
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Kedar Drugs And Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneet Kathuria  | Director | 01-Jul-2023 | Current |
| Vimal Mehta | Director | 24-Mar-2022 | Current |
| Parveen Kumar | Director | 24-Mar-2022 | Current |
Financial Performance of Kedar Drugs And Pharmaceuticals.
Kedar Drugs And Pharmaceuticals Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 3042.79% decrease in profit. The company's net worth Soared by an impressive increase of 45040%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kedar Drugs And Pharmaceuticals?
Unlock access to Kedar Drugs And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Brainwave Healthcare Private LimitedVimal Mehta and Parveen Kumar are mutual person
- Kedar Ayurveda Private Limited
Vimal Mehta and Parveen Kumar are mutual person
- Aitus Healthcare Limited
Vimal Mehta and Parveen Kumar are mutual person
- Astrokedar Informatics Private Limited
Vimal Mehta is a mutual person
- Mindmantra Healthcare Llp
Puneet Kathuria is a mutual person
Charges (Loans)
₹11.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 11.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Sep 2024 | Others | ₹4.00 Cr | Open |
| 20 Mar 2024 | Others | ₹5.00 Cr | Open |
| 20 Mar 2024 | Others | ₹2.00 Cr | Open |
How Many Employees Work at Kedar Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Kedar Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kedar Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kedar Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.